Stonebridge Capital Management Inc. Trims Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Stonebridge Capital Management Inc. trimmed its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,816 shares of the medical instruments supplier’s stock after selling 1,000 shares during the quarter. Stonebridge Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $908,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. First Community Trust NA acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $163,000. Oak Thistle LLC boosted its stake in shares of DENTSPLY SIRONA by 93.2% in the fourth quarter. Oak Thistle LLC now owns 31,590 shares of the medical instruments supplier’s stock valued at $600,000 after buying an additional 15,240 shares in the last quarter. Pallas Capital Advisors LLC purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth $264,000. Nordea Investment Management AB grew its position in DENTSPLY SIRONA by 245.0% during the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after buying an additional 178,639 shares during the period. Finally, Everence Capital Management Inc. purchased a new stake in DENTSPLY SIRONA during the fourth quarter worth $342,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

XRAY opened at $18.24 on Thursday. The company’s 50 day simple moving average is $18.85 and its 200 day simple moving average is $22.94. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $36.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the previous year, the company posted $0.49 earnings per share. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.51%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on XRAY. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Barrington Research reduced their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Mizuho assumed coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Morgan Stanley lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Nine research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $27.27.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.